Grade My Investments

Vor Biopharma Inc. (VOR) Stock Grade

VOR · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$992.1M
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
423.6%
Dividend Yield
None

About Vor Biopharma Inc.'s fundamentals

Vor Biopharma is a biotechnology company with a market capitalization of $992.1 million that currently generates no revenue, as indicated by its zero percent year-over-year revenue growth and zero percent net margin. The company reported a net loss in its latest annual statement, which explains the absence of a P/E ratio and the lack of any dividend yield. The reported return on equity of 423.6% reflects the company's negative earnings relative to shareholder equity, a metric that can appear unusually high when a company is operating at a loss.

Track VOR free — no credit card required. Live grade + monthly AI report →